// App-Quantinova.ai

AEP801 : 11-Ketotestosterone is the Predominant Androgen in Castration Resistant Prostate Cancer

Researchers

Presenter

  • Gido Snaterse

Principal Investigators

  • Lisanne F van Dessel

  • Job van Riet

  • Angela E Taylor

  • Jenny A Visser

  • Wiebke Arlt

  • Martijn P Lolkema

  • Hans Hofland

Medical Centers

  • VU University Medical Center, Internal medicine, Amsterdam, Netherlands

  • Erasmus University Medical Center, Department of Pediatric Oncology, Rotterdam, Netherlands

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, United Kingdom

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisolone

  • Cabazitaxel

  • Prednisone

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved